← Leaderboards
Chinnaswamy Jagannath
University Of Texas Hlth Sci Ctr Houston
$18,759,576
Attributed
$28,328,041
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,328,041 · 13
By mechanism
R01$27,118,587 · 9
R21$1,134,704 · 3
R03$74,750 · 1
Top collaborators
- Janice J Endsley7 shared
- Marie-Claire Elisabeth Gauduin5 shared
- Deepak Kaushal5 shared
- Arshad Khan2 shared
- Blanca I Restrepo2 shared
- Guohua Yi2 shared
- Jeffrey D. Cirillo1 shared
- Biana Godin1 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Michael C Braun$2,940,824
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisTuberculosisMacrophageResponseT-LymphocyteTuberculosis VaccinesVaccinesMediatingImmuneAntigensAntitubercular AgentsGenesImmune ResponseImmune SystemImmunogenicityPhenotypeAdultAttenuatedImmunityImmunogenicInfectionPreventCause Of DeathMortality
Grant awards (45)
Regulation of innate immunity by self-adjuvated MRNA vaccines$2,710,680
R01 · FY2025 · AI · contact PI
Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages$1,236,573
R01 · FY2025 · AI · contact PI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$948,345
R01 · FY2025 · AI · contact PI
Molecular basis of BCG vaccine sub-strain heterogeneity$749,192
R01 · FY2025 · AI
Sirtuin -Dependent Regulation of Tuberculosis and HIV Interactions in Macrophages$1,297,775
R01 · FY2024 · AI · contact PI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$958,345
R01 · FY2024 · AI · contact PI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$959,375
R01 · FY2023 · AI · contact PI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$959,375
R01 · FY2022 · AI · contact PI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$867,304
R01 · FY2022 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis$974,750
R01 · FY2021 · AI · contact PI
A Neonatal Monkey Model of Tuberculosis Vaccination$893,080
R01 · FY2021 · AI · contact PI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$877,748
R01 · FY2021 · AI
Role of metabolic Me-macrophages in the pathogenesis of tuberculosis during diabetes$197,530
R21 · FY2021 · AI
A Neonatal Monkey Model of Tuberculosis Vaccination$896,046
R01 · FY2020 · AI · contact PI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$872,044
R01 · FY2020 · AI
Evaluation of immune responses to CD44-targeted nanovectors for designing a novel anti-tuberculosis host-directed therapy$258,925
R21 · FY2020 · AI
Role of metabolic Me-macrophages in the pathogenesis of tuberculosis during diabetes$245,374
R21 · FY2020 · AI
A Neonatal Monkey Model of Tuberculosis Vaccination$919,284
R01 · FY2019 · AI · contact PI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$904,277
R01 · FY2019 · AI
Mesenchymal Stem Cell Niche for Tuberculosis$201,875
R21 · FY2019 · AI · contact PI
A Neonatal Monkey Model for Tuberculosis Vaccination$890,384
R01 · FY2018 · AI · contact PI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB$837,967
R01 · FY2018 · AI
MESENCHYMAL STEM CELL NICHE FOR TUBERCULOSIS$231,000
R21 · FY2018 · AI · contact PI
A Neonatal Monkey Model for Tuberculosis Vaccination$903,746
R01 · FY2017 · AI · contact PI
Mechanisms of Mycobacterial Antigen Processing$392,842
R01 · FY2013 · AI · contact PI
Mechanisms of Mycobacterial Antigen Processing$423,080
R01 · FY2012 · AI · contact PI
Mechanisms of Mycobacterial Antigen Processing$434,064
R01 · FY2011 · AI · contact PI
Chracteristics of An M. Tuberculosis Derived Vaccine$367,538
R01 · FY2011 · AI · contact PI
Mechanisms of Mycobacterial Antigen Processing$444,974
R01 · FY2010 · AI · contact PI
Chracteristics of An M. Tuberculosis Derived Vaccine$371,250
R01 · FY2010 · AI · contact PI
Mechanisms of Mycobacterial Antigen Processing$463,509
R01 · FY2009 · AI · contact PI
Chracteristics of An M. Tuberculosis Derived Vaccine$375,000
R01 · FY2009 · AI · contact PI
Chracteristics of An M. Tuberculosis Derived Vaccine$128,805
R01 · FY2009 · AI · contact PI
Chracteristics of An M. Tuberculosis Derived Vaccine$354,475
R01 · FY2008 · AI · contact PI
Characterization of an M. tuberculosis vaccine$362,526
R01 · FY2006 · AI · contact PI
Characterization of an M. tuberculosis vaccine$371,250
R01 · FY2005 · AI
Reactivation Tuberculosis in A/J$371,250
R01 · FY2005 · HL
Reactivation Tuberculosis in A/J$371,250
R01 · FY2004 · HL
Characterization of an M. tuberculosis vaccine$371,250
R01 · FY2004 · AI
Characterization of an M. tuberculosis vaccine$372,084
R01 · FY2003 · AI
Reactivation Tuberculosis in A/J Mice$371,354
R01 · FY2003 · HL
Reactivation Tuberculosis in A/J Mice$373,646
R01 · FY2002 · HL
Characterization of an M. tuberculosis vaccine$368,400
R01 · FY2002 · AI
Reactivation Tuberculosis in A/J Mice$373,750
R01 · FY2001 · HL
ROLE OF ADHESION MOLECULES IN REACTIVATION TUBERCULOSIS$74,750
R03 · FY2001 · AG